BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $551,000 | +5.6% | 5,060 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $522,000 | -8.3% | 5,060 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $569,000 | -1.2% | 5,060 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $576,000 | +2.1% | 5,060 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $564,000 | -7.5% | 5,060 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $610,000 | +1.3% | 5,060 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $602,000 | +7.5% | 5,060 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $560,000 | -7.9% | 5,060 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $608,000 | -27.9% | 5,060 | -28.3% | 0.01% | -37.5% |
| Q2 2017 | $843,000 | +0.7% | 7,060 | 0.0% | 0.01% | +14.3% |
| Q1 2017 | $837,000 | +0.7% | 7,060 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $831,000 | -6.0% | 7,060 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $884,000 | -36.9% | 7,060 | -41.5% | 0.01% | -10.0% |
| Q2 2016 | $1,400,000 | -2.5% | 12,060 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $1,436,000 | -11.2% | 12,060 | 0.0% | 0.01% | -9.1% |
| Q4 2015 | $1,618,000 | – | 12,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,326,025,000,000 | 1.66% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,643,000 | 0.79% |
| OAKTREE CAPITAL MANAGEMENT LP | 37,500,000 | $40,523,000 | 0.74% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 46,800,000 | $50,350,000 | 0.63% |
| Jabre Capital Partners S.A. | 6,500,000 | $7,035,000 | 0.54% |
| Nicholas Investment Partners, LP | 6,470,000 | $6,919,000 | 0.53% |
| Polar Asset Management Partners Inc. | 10,000,000 | $10,788,000 | 0.46% |
| AVIVA PLC | 50,700,000 | $54,594,000 | 0.46% |
| Man Investments (CH) AG | 1,000,000 | $1,082,000 | 0.44% |
| RWC Asset Management LLP | 3,500,000 | $3,769,000 | 0.40% |